Electronic Data Management As A Basis For Health Innovation In Europe
Speakers
Dr. Jens Baas is CEO of Techniker Krankenkasse. His vision is a public health insurance for the digital age. TK is Germany's largest statutory health insurance with more than 11 million people insured. Baas is overseeing Business Development, Finance/Controlling, Information Technology, Brand/Marketing, Politics/Communications and the Board of Directors/Executive Board. Previously he worked for the Boston Consulting Group as a Partner and Managing Director responsible for payers & providers, and also serving the pharmaceutical and medical technology industries. Baas holds a degree in human medicine from the University of Heidelberg. After graduating, he worked in the surgical department at the university hospitals of Heidelberg and Münster.
China correspondent for Handelsblatt in Beijing. Previously, four years as correspondent for Handelsblatt in Berlin, reporting on: Federal Ministry of Economics, digital policy, cybersecurity, SMEs, FDP. 2016 Arthur F. Burns Fellow at The Wall Street Journal in San Francisco.
Previously: interim head of the business desk at Handelsblatt Online. 2012 freelance correspondent in San Sebastián, northern Spain.
My editorial research has so far taken me to disused nuclear power plants in Germany and innovative companies in Silicon Valley, all the way to Fukushima Prefecture, which I visited in 2013 for a major multimedia project that won several awards (including the Ernst Schneider Journalism Prize).
I learned journalism, the interpretation of balance sheets, macro- and microeconomics while studying economics at the University of Bremen and at the Georg von Holtzbrinck School for Business Journalists.
Medical Doctor with many years as clinician and over 20 years in the pharmaceutical industry, now in digital health care. Amongst others, he was global head of the future program Teva 2021 for digital patient care. Before joining gematik, he was SVP Shionogi, responsible for the introduction of antibiotics for bacterial resistance with the highest WHO priority, SVP at Intermune and VP at Novo Nordisk.
As CEO of gematik now leading a competent team to deliver the reliable and secure digital platform for Germany´s health care system. Potentially offering a connection of 70 mio people with almost 200.000 doctors, 20.000 pharmacies, 2.000 clinics an over 100 sick-funds and all important care specialists e.g. physiotherapists, home-care nurses and care-givers.
Christiane Woopen has been Heinrich Hertz Professor of Life Ethics at the University of Bonn and founding director of the Center for Life Ethics since October 2021. Previously, she was Professor of Ethics and Theory of Medicine at the University of Cologne, where she was Founding Director of the interfaculty Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (ceres). In addition to leading national and international research projects, she is involved in policy advocacy, including as Chair of the German Ethics Council (2012-2016), as President of the Global Summit of National Ethics Councils (2014-2016), as a member of the UNESCO International Bioethics Committee until 2017, as Co-Spokesperson of the German Government Data Ethics Council from 2018 - 2019, and as Chair of the European Group on Ethics in Science and New Technologies (EGE) from 2017 to 2021. Woopen is a member of several academies of sciences (NRW, BBAW, Academia Europaea) and was awarded the Federal Cross of Merit 1st Class.
Prof. Eyal Zimlichman serves as Deputy Director General, Chief Medical Officer, and Chief Innovation Officer at Sheba Medical Center, Israel's largest hospital. Previously, he held the position of Lead Researcher at Partners HealthCare's Clinical Affairs Department in Boston and was heavily involved in the efforts to implement a strategic care redesign initiative there. Prof. Zimlichman has served on several advisory committees commissioned by the Office of the National Coordinator for health information technology at the U.S. Department of Health and Human Services and is chairing as well as participating in several committees at Israel's Ministry of Health. He is also a founding member of the International Academy for Quality and Patient Safety.
Prof. Zimlichman is the founder and director of Sheba's ARC innovation program, which aims to redesign healthcare through digital health solutions by 2030. He is board certified in internal medicine, completed a degree at the Harvard T.H. Chan School of Public Health, and has earned his MD at the Technion Israel Institute of Technology.